COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

(2020) Aiping Wu et al.   Cell Host & Microbe

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

(2020) Qiurong Ruan et al.   INTENSIVE CARE MEDICINE

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

(2020) Yushun Wan et al.   JOURNAL OF VIROLOGY

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

COVID-19 and the cardiovascular system

(2020) Ying-Ying Zheng et al.   Nature Reviews Cardiology

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

(2020) Syed Faraz Ahmed et al.   Viruses-Basel

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

(2020) Xiaolong Tian et al.   Emerging Microbes & Infections

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

(2020) Liang Chen et al.   CARDIOVASCULAR RESEARCH

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

(2020) Carly G.K. Ziegler et al.   CELL

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

(2020) Zhuo Zhou et al.   Cell Host & Microbe

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

(2020) Evangelos J. Giamarellos-Bourboulis et al.   Cell Host & Microbe

COVID-19 and the Heart

(2020) Akbarshakh Akhmerov et al.   CIRCULATION RESEARCH

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

(2020) Luka Nicin et al.   EUROPEAN HEART JOURNAL

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study

(2020) Maryam Enayatkhani et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs

(2020) Abhigyan Choudhury et al.   JOURNAL OF MEDICAL VIROLOGY

Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19

(2020) Jiewen Fu et al.   MOLECULAR BIOLOGY REPORTS

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

(2020) Ulf Andersson et al.   MOLECULAR MEDICINE

Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019

(2020) Lin Li et al.   Biomed Research International

Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response

(2020) Han Zhu et al.   Current Cardiology Reports

Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?

(2020) Harald Murck   Frontiers in Immunology

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

(2020) Xin Zou et al.   Frontiers of Medicine

Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach

(2020) Abdus Samad et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Targeting human TLRs to combat COVID‐19: A solution?

(2020) Ritwik Patra et al.   JOURNAL OF MEDICAL VIROLOGY

Alveolar lipids in pulmonary disease. A review

(2020) Christina W. Agudelo et al.   Lipids in Health and Disease

Longitudinal analyses reveal immunological misfiring in severe COVID-19

(2020) Carolina Lucas et al.   NATURE

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Clinical characteristics of 82 cases of death from COVID-19

(2020) Bicheng Zhang et al.   PLoS One

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

(2020) Jérôme Hadjadj et al.   SCIENCE

Type III interferons disrupt the lung epithelial barrier upon viral recognition

(2020) Achille Broggi et al.   SCIENCE

A candidate multi-epitope vaccine against SARS-CoV-2

(2020) Tamalika Kar et al.   Scientific Reports

Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach

(2020) M. Shaminur Rahman et al.   PeerJ

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

(2020) Valentina O. Puntmann et al.   JAMA Cardiology

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

(2020) Muhammad Adnan Shereen et al.   Journal of Advanced Research

Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach

(2020) Noor Rahman et al.   Vaccines

Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?

(2020) Simone Cristina Soares Brandão et al.   CYTOKINE & GROWTH FACTOR REVIEWS

A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1β signaling interruption

(2020) Ahmed E. Khodir et al.   LIFE SCIENCES

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

(2020) Jeffrey Seow et al.   Nature Microbiology

Phospholipid regulation of innate immunity and respiratory viral infection

(2019) Dennis R. Voelker et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases

(2019) Mahesh Chandra Patra et al.   SEMINARS IN CANCER BIOLOGY

Ablation of Toll-like receptor 9 attenuates myocardial ischemia/reperfusion injury in mice

(2019) Rika Kitazume-Taneike et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Activation of NLRP3 inflammasome by lymphocytic microparticles via TLR4 pathway contributes to airway inflammation

(2019) Qian Qiu et al.   EXPERIMENTAL CELL RESEARCH

ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway

(2019) Rensong Ye et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury

(2018) Qiang Su et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats

(2018) Eman Said et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model

(2018) Ruhui Yang et al.   ATHEROSCLEROSIS

Platelet TLR4 at the crossroads of thrombosis and the innate immune response

(2018) Mirta Schattner   JOURNAL OF LEUKOCYTE BIOLOGY

Toll-like receptor 4 in acute viral infection: Too much of a good thing

(2018) Judith Olejnik et al.   PLoS Pathogens

Angiotensin-(1–7) and Vascular Function

(2017) Rhian M. Touyz et al.   HYPERTENSION

MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line

(2017) Man Luo et al.   MOLECULAR IMMUNOLOGY

Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use

(2017) Huijie Jia et al.   Molecular Medicine Reports

The interplay between Angiotensin II, TLR4 and hypertension

(2017) Vinicia Campana Biancardi et al.   PHARMACOLOGICAL RESEARCH

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection

(2017) Mathieu Iampietro et al.   PLoS Pathogens

Integration of Canonical and Noncanonical Pathways in TLR4 Signaling: Complex Regulation of the Wound Repair Program

(2017) Paula J. McKeown-Longo et al.   Advances in Wound Care

Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma

(2017) Swati Bhattacharyya et al.   Advances in Wound Care

TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review

(2016) Suprabhat Mukherjee et al.   Brazilian Journal of Infectious Diseases

Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis

(2016) Sally A. Huber   CURRENT PHARMACEUTICAL DESIGN

Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)

(2016) Neil A. Turner   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation

(2016) Monica Molteni et al.   MEDIATORS OF INFLAMMATION

Novel strategies for targeting innate immune responses to influenza

(2016) K A Shirey et al.   Mucosal Immunology

Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases

(2016) B. García Bueno et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Evolution of surfactant therapy for respiratory distress syndrome: past, present and future

(2016) Smeeta Sardesai et al.   PEDIATRIC RESEARCH

Corticosteroids

(2016) Sivapriya Ramamoorthy et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern To Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent Mechanism

(2016) Yi Wang et al.   mBio

The emerging role of Toll-like receptor 4 in myocardial inflammation

(2016) Y Yang et al.   Cell Death & Disease

TLR4-Upregulated IL-1β and IL-1RI Promote Alveolar Macrophage Pyroptosis and Lung Inflammation through an Autocrine Mechanism

(2016) Xingying He et al.   Scientific Reports

HMGB1 Neutralizing Antibody Attenuates Cardiac Injury and Apoptosis Induced by Hemorrhagic Shock/Resuscitation in Rats

(2015) Yu Zhou et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Toll-like receptor 4 promotes fibrosis in bleomycin-induced lung injury in mice

(2015) X.X. Li et al.   GENETICS AND MOLECULAR RESEARCH

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

(2015) Allison L. Totura et al.   mBio

Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1

(2014) Yun-peng Luo et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Cardiac Fibroblasts Contribute to Myocardial Dysfunction in Mice with Sepsis: The Role of NLRP3 Inflammasome Activation

(2014) Wenbo Zhang et al.   PLoS One

Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome

(2014) Tiffany Horng   TRENDS IN IMMUNOLOGY

Immunomodulatory activity of interferon-beta

(2014) Lloyd H. Kasper et al.   Annals of Clinical and Translational Neurology

Suppression of TLR-4-Related Inflammatory Pathway and Anti-Fibrosis Effects of Probiotic-Fermented Purple Sweet Potato Yogurt in Hearts of Spontaneously Hypertensive Rats

(2013)   CHINESE JOURNAL OF PHYSIOLOGY

TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review

(2013) Yu Liu et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Pathogenesis of influenza-induced acute respiratory distress syndrome

(2013) Kirsty R Short et al.   LANCET INFECTIOUS DISEASES

Protein Kinase C -Calcineurin Cosignaling Downstream of Toll-Like Receptor 4 Downregulates Fibrosis and Induces Wound Healing Gene Expression in Cardiac Myofibroblasts

(2013) R. F. D. S. Mesquita et al.   MOLECULAR AND CELLULAR BIOLOGY

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

(2013) Kari Ann Shirey et al.   NATURE

Surfactant Replacement Therapy for Preterm and Term Neonates With Respiratory Distress

(2013) Richard A. Polin et al.   PEDIATRICS

Differential Response of Primary Alveolar Type I and Type II Cells to LPS Stimulation

(2013) Mandi H. Wong et al.   PLoS One

Make Yourself at Home: Viral Hijacking of the PI3K/Akt Signaling Pathway

(2013) Nora Diehl et al.   Viruses-Basel

Diverse Functions of Pulmonary Collectins in Host Defense of the Lung

(2012) Shigeru Ariki et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Diagnosis and Treatment of Viral Myocarditis

(2012) Jason C. Schultz et al.   MAYO CLINIC PROCEEDINGS

Lipopolysaccharide Induces Lung Fibroblast Proliferation through Toll-Like Receptor 4 Signaling and the Phosphoinositide3-Kinase-Akt Pathway

(2012) Zhengyu He et al.   PLoS One

CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4

(2011) Ivan Zanoni et al.   CELL

Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome

(2011) A. Kaparianos et al.   CURRENT MEDICINAL CHEMISTRY

The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy

(2011) Heidi Ehrentraut et al.   EUROPEAN JOURNAL OF HEART FAILURE

TRIF Is a Critical Survival Factor in Viral Cardiomyopathy

(2011) A. Riad et al.   JOURNAL OF IMMUNOLOGY

Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction

(2011) Gemma Vilahur et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway

(2011) Leonid Tarassishin et al.   Journal of Neuroinflammation

Interferon-stimulated genes and their antiviral effector functions

(2011) John W Schoggins et al.   Current Opinion in Virology

Psoriasis and extra domain A fibronectin loops

(2010) J.P. McFadden et al.   BRITISH JOURNAL OF DERMATOLOGY

Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts

(2010) J. P. Burke et al.   BRITISH JOURNAL OF SURGERY

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*

(2010) Todd W. Rice et al.   CRITICAL CARE MEDICINE

Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury

(2010) Hiroyuki Seki et al.   INFLAMMATION RESEARCH

TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules

(2010) N. Matsunaga et al.   MOLECULAR PHARMACOLOGY

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release

(2010) H. Yang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pulmonary Surfactant: An Immunological Perspective

(2009) Zissis Chroneos et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2

(2009) Koji Kuronuma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains

(2009) Wondwossen Abate et al.   JOURNAL OF LIPID RESEARCH

Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion

(2008) Ning Zou et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

(2008) Yumiko Imai et al.   CELL

TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β

(2008) Jonathan C Kagan et al.   NATURE IMMUNOLOGY

MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV

(2008) Timothy Sheahan et al.   PLoS Pathogens

Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction

(2007) Leo Timmers et al.   CIRCULATION RESEARCH